Patent · US Active

Reduction of off-target RNA interference toxicity

US10093927B2 · kind B2 · utility

8Cited by
22References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 7, 2017
Grant dateOct 9, 2018
Priority date
Expiry dateApr 7, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2330/51
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention is directed to RNA interference (RNAi) molecules targeted against a nucleic acid sequence, and methods of using these RNAi molecules to reduce off-target toxicity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.